Welcome to visit Zhongnan Medical Journal Press Series journal website!
Zhongnan Medical Journal Press
Series of Journals
Center for Evidence-Based and Translational Medicine of Wuhan University
The title
The title
The keywords
The author
Submit
Home
About us
Journal Introduction
Chief Editor
Editorial Committee
Author Center
Submission Guide
Assignment Agreement
Articles
Subscribe
Copyright
Contact us
Draft submission system
Author login
Author register
Reviewer login
Editor login
Home
Results
The title
The title
The keywords
The author
A total of
10
result was found. Results that relate to
Type 2 diabetes
口服益生菌用于2型糖尿病成年患者效果的 Meta 分析
Yun-Jie TENG
Ying-Hong WANG
Jing CHEN
Ming-Chen ZHANG
DOI:10.19960/j.issn.1005-0698.202301009
Probiotics
Type 2 diabetes
Adults
Meta-analysis
Meta-regression
Randomized controlled trial
Details
Download
Mobile
达格列净联合美托洛尔治疗2型糖尿病合并阵发性心房颤动的临床观察
Mei DONG
Xu-Du SUN
Shan ZHANG
DOI:10.19960/j.issn.1005-0698.202306004
Dagglizin
Metoprolol
Type 2 diabetes
Paroxysmal atrial fibrillation
Atrial elec-trophysiological parameters
P wave dispersion
Details
Download
Mobile
度拉糖肽治疗2型糖尿病的快速卫生技术评估
Yuan YAO
Fen-Li SU
Xu SUN
Shi-Yin FENG
Fen XIONG
Qing-Qun CAI
DOI:10.19960/j.issn.1005-0698.202308012
Dulaglutide
Type 2 diabetes
mellitus
Rapid health technology assessment
Details
Download
Mobile
基础胰岛素联合口服降糖药治疗效果不佳的2型糖尿病患者的治疗策略选择:伞形评价
Ya-Ping NIU
San-Bao CHAI
Jing-Zi MA
Meng ZHANG
Zuo-Xiang LIU
Shan-Shan WU
Feng SUN
DOI:10.19960/j.issn.1005-0698.202311011
Basal insulin
Oral hypoglycemic agents
Type 2 diabetes
mellitus
Poor treatment effect
Umbrella review
Details
Download
Mobile
西安市药店慢病管理的2型糖尿病患者用药和血糖控制情况分析
ZHU Xiaoying
REN Biqi
SU Xinyue
LEI Shuang
LIN Shuzhi
LIU Wei
FENG Bianling
DOI:10.12173/j.issn.1005-0698.202304126
Type 2 diabetes
Medication
Blood glucose control
Chronic disease management
Details
Download
Mobile
基于Markov模型的胰高血糖素样肽1受体激动剂联合二甲双胍治疗2型糖尿病药物经济学评价
YU Tian
LIU Shaohua
WEI Anhua
GUO Jieru
ZHANG Chengliang
LIU Dong
LIU Zhelong
DOI:10.12173/j.issn.1005-0698.202304014
Glucagon-like peptide-1 receptor agonist
Metformin
Type 2 diabetes
mellitus
Cost-utility
Markov model
Pharmacoeconomics
Details
Download
Mobile
胰高血糖素样肽1受体激动剂治疗合并超重或肥胖的2型糖尿病的疗效和安全性的Meta分析
YU Tian
LIU Shaohua
WEI Anhua
GUO Jieru
ZHANG Chengliang
LIU Dong
LIU Zhelong
DOI:10.12173/j.issn.1005-0698.202306027
Glucagon-like peptide 1 receptor agonists
Type 2 diabetes
mellitus
Obesity or overweight
Efficacy
Safety
Meta-analysis
Randomized controlled trial
Details
Download
Mobile
司美格鲁肽和度拉糖肽治疗2型糖尿病的疗效与安全性比较:基于倾向性评分匹配的回顾性队列研究
HE Lanzhi
ZHOU Pengxiang
HUANG Shulin
LIN Chunyan
LUO Haikun
QI Jianying
ZHANG Hongliang
CHEN Xiaoyu
ZHOU Ganping
DOI:10.12173/j.issn.1005-0698.202401055
Type 2 diabetes
Semaglutide
Dulaglutide
Effectiveness
Safety
Propensity score matching
Generalized estimation equation
Details
Download
Mobile
艾托格列净治疗2型糖尿病的快速卫生技术评估
QIN Fang
WU Kunrong
LIU Chengyu
LIU Daihua
DOI:10.12173/j.issn.1005-0698.202405068
Ertugliflozin
Type 2 diabetes
mellitus
Efficacy
Safety
Cost-effectiveness
Rapid health technology assessment
Details
Download
Mobile
他汀类药物与1型或2型糖尿病的因果关系:一项两样本孟德尔随机化研究
WENG Liyan
WENG Jinyan
XU Jing
DOI:10.12173/j.issn.1005-0698.202403050
Statins
Type 1 diabetes
Type 2 diabetes
Causality
Mendelian randomization
Genome-wide association study
Details
Download
Mobile